Skip to main content
. 2021 Jul 22;17(10):3421–3432. doi: 10.1080/21645515.2021.1893069

Table 2.

Factors associated with negative attitudes toward a future COVID-19 vaccine by gender (COCONEL 2020, N = 5,018)

    All (n = 5,018)
Women (n = 2,635)
Men (n = 2,383)
    Row % Adjusted OR [95% CI] Row % Adjusted OR [95% CI] Row % Adjusted OR [95% CI]
Gender   ***          
 Men   20.6 0.77 [0.67;0.89]***        
 Women   27.1 –1–        
Date of survey   **   **      
 7–26 April   22.6 –1– 25.0 –1– 20.0 –1–
 30 April – 04 May   26.0 1.18 [1.03;1.36]* 30.2 1.25 [1.03;1.50]* 21.5 1.14 [0.92;1.41]
Age ***   ***   ***  
 18–24   33.1 1.08 [0.87;1.35] 33,1 0.83 [0.62;1.10] 30.1 1.66 [1.16;2.37]**
 25–34     1.09 [0.90; 1.32]   0.97 [0.75; 1.24]   1.30 [0.97; 1.75]
 35–54     –1–   –1–   –1–
 55–64   25.8 0.72 [0.58; 0.89]** 25.8 0.69 [0.52; 0.93]* 18.7 0.77 [0.56; 1.06]
 65–74   11.8 0.62 [0.46; 0.82]** 10.7 0.45 [0.31;0.67]*** 12.0 0.93 [0.60;1.44]
 > 74   9.6 0.60 [0.43;0.82]** 13.6 0.61 [0.40;0.94]* 6.3 0.54 [0.32;0.90]*
Education level   *       *  
 High school degree or lower   27.5 –1– 29.2 –1– 25.1 –1–
 Higher than High school degree   22.5 0.82 [0.70;0.96]* 27.5 0.84 [0.68;1.04] 18.4 0.77 [0.60;0.99]*
Being in a couple   ***   **   **  
 Yes   21.8 0.79 [0.68;0.92]** 25.0 0.69 [0.57;0.84]*** 18.6 0.98 [0.77;1.24]
 No   27.4 –1– 29.9 –1– 24.1 –1–
EHI   ***   ***   ***  
 Low   31.8 1.62 [1.28;2.06]*** 33.6 1.40 [1.01;1.92]* 28.8 2.03 [1.42; 2.90]***
 Intermediate   24.8 1.50 [1.22;1.84]*** 26.6 1.38 [1.03;1.84]* 22.8 1.65 [1.22; 2.23]**
 High   14.5 –1– 19.9 –1– 11.0 –1–
 Missing   24.5 1.05 [0.83;1.32] 25.0 1.14 [0.84;1.53] 23.7 0.91 [0.63;1.32]
Living in a region strongly by impacted COVID-19   ns   ns   *  
 Yes   22.7 0.89 [0.78; 1.03] 27.2 1.03 [0.85;1.24] 18.1 0.75 [0.60;0.93]**
 No   24.8 –1– 27.0 –1– 22.4 –1–
Vaccinated against the flu the year before   ***   ***   ***  
 Yes   5.5 0.17 [0.13; 0.22]*** 5,5 0.14 [0.10;0.21]*** 5.4 0.19 [0.13;0.28]***
 No   31.3 –1– 34.2 –1– 27.8 –1–
COVID-19-related concern   ***   ***   ***  
 High (>8)   16.9 0.60 [0.50;0.73]*** 19.0 0.60 [0.48;0.76]*** 13.6 0.61 [0.44;0.84]**
 Lower   25.8 –1– 29.7 –1– 22.0 –1–
Friends or relatives diagnosed with COVID-19   *   $   $  
 Yes   21.1 0.83 [0.70;0.98]* 24.1 0.84 [0.66;1.06] 18.0 0.82 [0.63;1.06]
 No   24.8 –1– 27.9 –1– 21.3 –1–
Diagnosed with COVID-19   ns   ns   $  
 Yes   23.8 NI 18.7 NI 29.0 NI
 No   24.0 27.3 20.3

Chi-Square test: $p < 0.10; *p ≤ 0.05; ** p < 0.01; p < 0.001. NI covariate not included in the model because of small effectives. Note: The following model fit measures were use: Likelihood ratio test: −2Log (Model for All) – [−2Log (Model for Women) + −2Log (Model for Men)] = 4919.504–4890.198 = 29.306, p < 0.001, which confirms the relevance of gender stratification. In addition, the Nagelkerke R2 = 0.1710 for the model for all, 0.1712 for the model among women and 0.1712 for the model performed among men. Population: respondents for the COCONEL surveys 7–9 April wave, 15–17 April wave, 24–26 April wave, and 30 April- 4 May wave (N = 5,018).